Related Experiment Video
Updated: Aug 9, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Organ dysfunction as an outcome measure in clinical trials
1Department of Surgery, University of Toronto, Ontario, Canada. jmarshall@torhosp.toronto.on.ca
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|July 13, 2000
Summary
A new model quantifies multiple organ dysfunction syndrome (MODS) to assess treatment effectiveness in serious infections. This tool evaluates both biological effects and clinical benefits for better patient outcomes.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Clinical Trial Methodology
Background:
- Serious infections cause significant morbidity and mortality.
- Multiple organ dysfunction syndrome (MODS) is a key complication of severe infections.
- Reliable tools are needed to evaluate treatments for infections and MODS.
Purpose of the Study:
- To present a model for quantifying MODS.
- To enable evaluation of both biological effect and clinical benefit of interventions.
- To utilize commonly measured variables for MODS assessment.
Main Methods:
- Development of a model based on a previously published MOD score.
- Inclusion of readily available and commonly measured variables.
- Designed to assess biological effect and clinical benefit.
Main Results:
- The model allows for the evaluation of biological effects.
- The model permits the assessment of clinical benefits.
- The model uses commonly available clinical data.
Conclusions:
- The described model is a potentially useful tool for evaluating new treatments for serious infections.
- The model aids in understanding the relationship between MODS biological processes and clinical signs.
- This approach supports improved assessment of patient outcomes in critical care settings.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...